CMC PHARMACEUTICALS, INC.

Solon, OH · Defense · Private

Multi-dose intramuscular scopolamine hydrobromide trihydrate (Scop-HBT) injectable formulation for nerve agent poisoning treatment

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · cmcpharm.com

Sector: Defense
Headquarters: Solon, OH
Total capital: $4.8M

Federal grants: $830K; 2 awards · 2022–2023; Rank in peer group#823 of 1418
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: $4M; 5 awards · Defense; Rank in Defense#575 of 1442
Granted patents: 0; 2 pending

Capital timeline

Latest events

Jun 2023Federal grantDefense · Phase II · Pharmaceutical Development, Planning, and CMO Identification for the Expedited Advancement of a Scopolamine Multi-Dose-Vial Drug Product$663K
Jun 2023Federal contractDefense · Phase II - Base Year$1.1M
Sep 2022Federal contractDefense · Phase II - Base Year$1.1M
Feb 2022Federal grantDefense · Phase I · Formulation and analytical development of a multi-dose vial presentation of scopolamine hydrobromide trihydrate containing a antimicrobial preservatives (AMP)$167K
Jan 2022Federal contractDefense · Feasibility Study, SBIR Phase I, Topic SOCOM213- 002, Concentrated Atropine Sulfate Formulations$149K
Oct 2019Federal contractDefense · Army SBIR Phase II$1.5M
Oct 2018Federal contractDefense · SBIR Ph I Award Topic CBD181-005$149K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1418 peers

Line = median

Defense · Molecule

Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 2

Dec 8, 2022PendingAtropine-scopolamine With Enhanced StabilityUSPTOApplication 17755055
PendingAtropine-scopolamine With Enhanced StabilityUSPTOApplication PCTUS2020057371

WANG ELECTRO-OPTO CORPORATIONSimilar federal contract value in Defense · $4M in contracts
HavocAI Inc.Similar federal contract value in Defense · $4M in contracts
ZEROEYES, INC.Similar federal contract value in Defense · $4M in contracts
LEGIONARIUS LLCSimilar federal contract value in Defense · $3.9M in contracts
CONDUCTORAI CORPORATIONSimilar federal contract value in Defense · $3.9M in contracts
HF DESIGNWORKS INCSimilar federal contract value in Defense · $3.9M in contracts

Regulatory activity · Defense

Sector-level, not company-level

11 Jun 2026Danger Zone; Waters of Carr Creek and Whitehall Bay in the Vicinity of the Naval Support Activity AnnapolisEngineers Corps
13 Mar 2026Federal Acquisition Regulation; Federal Acquisition Circular 2026-01; IntroductionNational Aeronautics and Space Administration
13 Mar 2026Federal Acquisition Regulation: Trade Agreements ThresholdsNational Aeronautics and Space Administration
13 Mar 2026Federal Acquisition Regulation; Federal Acquisition Circular 2026-01; Small Entity Compliance GuideNational Aeronautics and Space Administration
27 Aug 2025Federal Acquisition Regulation; Federal Acquisition Circular 2025-06; Small Entity Compliance GuideNational Aeronautics and Space Administration
27 Aug 2025Federal Acquisition Regulation; Federal Acquisition Circular 2025-06; IntroductionNational Aeronautics and Space Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.